Prevalence of smoking and the risk of cardiovascular diseases in power grid workers

Introduction: Smoking is a risk factor that contributes the most to premature mortality and disability from a whole range of malignant neoplasms, cardiovascular and respiratory diseases. Industrial workers are more likely to smoke compared to the general population, which may lead to a greater risk of their health impairment.

Objective: To analyze the relationship between the prevalence of smoking and the risk of developing diseases of the cardiovascular system in power grid workers.

Materials and methods: 2,651 men were examined at the clinic of Izmerov Research Institute of Occupational Health and divided into two groups of 1,107 non-smokers and 1,544 smokers. The examination included collection of a medical history, height and weight measurements, calculation of the body mass index (BMI), systolic and diastolic blood pressure measurements, and blood testing for glucose, cholesterol, and high-sensitivity C-reactive protein levels. The data were analyzed using Statistica 10.0 with the calculation of the means, their standard errors, minimum and maximum values for all indicators in the study groups; the analysis of the contingency tables was carried out using the chi-square test.

Results: The prevalence of hypertension in the smokers was significantly higher than in the non-smokers of all age groups, but for those aged 30 to 39 years. The number of workers with high total cholesterol (≥ 6.2 mmol/L) and, therefore, increased cardiovascular risks was statistically higher among the smokers aged 50–59 years (χ² = 5.323, p = 0.022) and 60 years and older (χ² = 4.475, p = 0.035). The level of high-sensitivity C-reactive protein posing a high cardiovascular risk (> 3 mg/L) was statistically higher in the smoking than in non-smoking workers.

Conclusion: Our findings show the necessity of considering smoking habits within pre-employment and periodic medical examinations in order to prevent risks of developing new or exacerbating already existing cardiovascular diseases.

1. Salagai OO, Bryun EA, Bukhtiyarov IV, et al. Methodological approaches to identifying markers of alcohol abuse in employees according to medical examination. Meditsina Truda i Promyshlennaya Ekologiya. 2021;61(2):72-76. (In Russ.) doi: 10.31089/1026-9428-2021-61-2-72-76

2. Salagay OO, Bukhtiyarov IV, Kuzmina LP, Bezrukavnikova LM, Khotuleva AG, Anvarul RA. The influence of smoking on the formation of occupational lung diseases in workers who come into contact with industrial aerosols. Obshchestvennoe Zdorov'e. 2021;1(3):32-41. (In Russ.) doi: 10.21045/2782-1676-2021-1-3-32-41

3. Gambaryan MG, Drapkina OM. Prevalence of tobacco consumption in Russia: Dynamics and trends. Analysis of global and national survey results. Profilakticheskaya Meditsina. 2018;21(5):45-62. (In Russ.) doi: 10.17116/profmed20182105145

4. Gadzhieva SR, Alieva TI, Gadzhieva HF. [The effect of tobacco on human health.] Molodoy Uchenyy. 2017;(44(178)):99-102. (In Russ.)

5. Ostroumova OD, Izvekov AA, Voevodina NYu. Smoking as a risk factor of cardiovascular and cerebrovascular diseases: Prevalence, impact on prognosis, possible smoking cessation strategies and their effectiveness. Part 1. Smoking prevalence and impact on prognosis. Ratsional'naya Farmakoterapiya v Kardiologii. 2017;13(6):871-879. (In Russ.) doi: 10.20996/1819-6446-2017-13-6-871-879

6. Salagay OO, Antonov NS, Sakharova GM, Peredelskaya MU, Starodubov VI. The effect of smoking on the development and progress of chronic bronchitis. Profilakticheskaya Meditsina. 2020;23(4):7-13. (In Russ.) doi: 10.17116/profmed2020230417

7. Kalabikhina IE, Kuznetsova PO, Tikunov VS, Chereshnia OYu. Smoking-associated mortality in Russian regions. Vestnik Moskovskogo Universiteta. Seriya 5: Geografiya. 2021;(6):13-26. (In Russ.)

8. Amiri S, Hosseini SM. Prevalence of current and former smoking in industrial workers worldwide: A systematic review and meta-analysis. J Addict Dis. 2021;39(3):288- 306. doi: 10.1080/10550887.2020.1860422

9. Raikova SV, Raykin SS, Komleva NE, Gadzhieva MK. The prevalence of tobacco use among industrial workers. Gigiena i Sanitariya. 2022;101(6):641-644. (In Russ.) doi: 10.47470/0016-9900-2022-101-6-641-644

10. Plavinski SL, Plavinskaya SI. Smoking and mortality in a large prospective study. Rossiyskiy Semeynyy Vrach. 2012;16(2):29-36. (In Russ.)

11. Khaltourina D, Zamiatnina E, Zubkova T. The impact of smoking on mortality in Russia in 2019. Demograficheskoe Obozrenie. 2021;8(1):81-105. (In Russ.) doi: 10.17323/demreview.v8i1.12394

12. Williams RJC. Heart rate and nicotine: A chronic problem. Mezhdunarodnyy Zhurnal Serdtsa i Sosudistykh Zabolevaniy. 2013;1(1):20-28. (In Russ.)

13. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016;26(6):515-523. doi: 10.1016/j.tcm.2016.03.001

14. Prokofieva EB. Smoking is a risk factor for the development of endothelial dysfunction in patients with arterial hypertension. (In Russ.) Accessed January 25, 204. https://www.lvrach.ru/2036/partners/15438014

15. Pinchuk AF, Mitkovskaya NP, Statkevich TV, Kartun LV. Predictors of adverse events in patients with different emotional status at postinfarction cardiosclerosis. Proceedings of the National Academy of Sciences of Belarus. Medical Series. 2015;(4):92-96. (In Russ.)

16. United States Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. Accessed January 24, 2024. https://stacks.cdc.gov/view/cdc/6067

17. Gupta R, Gurm H, Bartholomew JR. Smokeless tobacco and cardiovascular risk. Arch Intern Med. 2004;164(17):1845-1849. doi: 10.1001/archinte.164.17.1845

18. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EFM. Systemic effects of smoking. Chest. 2007;131(5):1557-1566. doi: 10.1378/chest.06-2179

19. Todua FI, Gachechiladze DG, Balavadze MB, Akhvlediani MV. Effect of atherogenic risk factors on the state of common carotid artery intima-media. Kardiologiya. 2003;43(3):50-53. (In Russ.)

20. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol. 2004;43(10):1731-1737. doi: 10.1016/j.jacc.2003.12.047

21. Sorokin GA, Syurin SA. Assessment of the impact of harmful working conditions and smoking on the health of industrial workers. Gigiena i Sanitariya. 2019;98(6):646- 651. (In Russ.) doi: 10.18821/0016-9900-2019-98-6- 646-651

22. Syurin SA, Gorbanev SA. Influence of smoking on the state of health of nickel electrolysis production workers. Zdorov'e Naseleniya i Sreda Obitaniya. 2017;(12(297)):21- 24. (In Russ.) doi: 10.35627/2219-5238/2017-297-12-21-24

23. Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25–26 August 2002, Washington, DC. Diabetes Care. 2003;26(3):933-939. doi: 10.2337/diacare.26.3.933

24. Kuzmina LP, Kislyakova AA, Bezrukavnikova LM. The prevalence of endocrine and cardiovascular pathology among workers exposed to magnetic fields. In: Profession and Health: Proceedings of the 16th Russian National Congress with international participation, Vladivostok, September 21–24, 2021. Moscow: NGO Association of Occupational Medicine Physicians and Specialists; 2021:293-295. (In Russ.) doi: 10.31089/978-5-6042929-2-1-2021-1-293-295

25. Moskalev AV, Sboychakov VB, Tsygan VN, Apchel AV. Chemokines’ role in immunopathogenesis of atherosclerosis. Vestnik Rossiyskoy Voenno-Meditsinskoy Akademii. 2018;(1(61)):195-202. (In Russ.) 26. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi: 10.3389/fimmu.2018.00754